-
Aug 23, 10 06:56PMThe purpose of this research is to determine if a film to prevent adhesions will improve the area of distribution of a contrast dye (representative of chemotherapy) in the abdominal cavity (belly) of women who have undergone surgery for ovarian cancer as compared with patients who have not had adhesion barrier sheets placed in the belly. It is believed that this film, S...Location: Vancouver General Hospital Status: Not yet recruiting» Read more
-
Apr 01, 10 10:54AMIn a phase II open-label study women with recurrent epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma will be treated with bevacizumab 15 mg/kg and irinotecan 250mg/m2 every 3 weeks.Location: New York University Clinical Cancer Center Status: Not yet recruiting» Read more
-
Aug 12, 10 12:25AMThe purpose of this study is to determine the safety and efficacy of an investigational vaccine in ovarian cancer patients in remission and to determine its ability to prevent cancer from returning.Location: California Cancer Care, Inc. Status: Recruiting» Read more
-
Aug 12, 10 02:12AMA supra-additive cytotoxic effect was seen when CAI and paclitaxel were given to human ovarian cancer cells sequentially in tissue culture. We have demonstrated that CAI given for 8 days followed by paclitaxel is reasonably well tolerated and that paclitaxel administration causes a dose-dependent increase in CAI plasma concentration. CAI is a cytostatic drug and contin...Location: National Institutes of Health Clinical Center, ... Status: Completed» Read more
-
Aug 12, 10 03:32AMRATIONAL FOR STUDYING IV NAC AS POTENTIAL CHEMOPROTECTANT: Cisplatin has shown efficacy in the treatment of subjects with epithelial ovarian cancer. Systemic toxicities associated with cisplatin include nephro, oto, and nerve toxicities. It may be possible to reduce the toxicities of cisplatin by administering it in conjunction with IV NAC. NAC may reduce cisplatin rel...Location: Oregon Health & Science University Status: Recruiting» Read more
-
Aug 12, 10 03:33AMThe best way to treat MBO in patients with ovarian cancer has not been studied enough by trials that assess how more than one treatment arm (surgical, chemotherapeutic, supportive care approaches) affects clinical outcomes like resolution of bowel obstruction, survival, and quality of life. To improve patient outcomes, we must assess which patients will do better with p...Location: Princess Margaret Hospital Status: Recruiting» Read more
-
Aug 12, 10 11:09AMThe purpose of this study is to determine if patients with p53 mutated epithelial ovarian cancer that have been treated with first line treatment (paclitaxel - carboplatin combination therapy) and that have shown early relapse (within 3 months) or progression during treatment will benefit from treatment with Wee-1 inhibitor MK-1775 and carboplatin.Location: Netherlands Cancer Institute - Antoni van Leeuw... Status: Recruiting» Read more
-
Aug 12, 10 11:09AMThis is a Phase II study to determine the feasibility of administering neoadjuvant carboplatin, paclitaxel, and bevacizumab without excessive dose modification or cycle delay in patients with epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.Location: Columbia University Medical Center Status: Recruiting» Read more
-
Aug 24, 10 10:26AMThe purpose of this study is to create new tests to identify biomarkers for ovarian cancer so that a screening test can be developed. For patients who have a diagnosis of ovarian Cancer, researchers will use blood samples before and after treatment to see if disease status can be determined by measuring the amount of biomarker.Location: University of Virginia Status: Not yet recruiting» Read more
-
Apr 13, 11 08:00AMIntend of use: A blood test for Cancer Associated Antibodies (CAAA) is an aid in initial diagnosis of ovarian cancer in women with suspected ovarian pathology as detected by primary diagnostic techniques. Test Description: Blood is collected from patients and serum/plasma is tested for the presence of CAAA on experimental test kit. Objectives: To assess the effec...Location: Eventus Diagnostics Status: Not yet recruiting» Read more
Ovarian Cancer
This community is for patients, students, caregivers, medical professionals, researchers, and anyone interested in learning more about ovarian cancer, cancer of the ovaries, epithelial ovarian tumors, stromal cell ovarian tumors, sex cord stromal ovarian tumors, germ cell ovarian tumors, low malignant potential ovarian tumors, stages of ovarian cancer, and other related topics.
Join to have conversations with knowledgeable people and get real-time updates
Question Guidelines
- Anything you write on Medpedia Answers is publicly viewable and searchable.
- Questions should be a request for information only — not a request for direct medical advice, a diagnosis, or a treatment plan.
Examples:
- Is a sore throat a symptom of swine flu?
- What are the benefits and drawbacks of a tonsillectomy?
-
Peter Hofland Ph.DEditor
Senior Editor, Sunvalley Communicatione
-
Program Director, National Cancer Institute
-
clinical researcher
-
Founder of Libby's H*O*P*E*
-
RHIT-on Disability
-
You must be a member of this Community to do that.
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates
You must be a member of this Community to do that.
Join this Community to:
- Ask a Question
- Start or Join a Discussion
- Get real-time email updates
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates